The company said it entered into an Equity Purchase Agreement with certain affiliates of Carlyle Group Inc. on August 12, 2024 to sell its Kidney Care business for an aggregate $3.80 billion. It said the transaction is expected to close in late 2024 or early 2025, subject to regulatory approvals and other closing conditions.

1. 01

   The company said it entered into an Equity Purchase Agreement with certain affiliates of Carlyle Group Inc. on August 12, 2024 to sell its Kidney Care business for an aggregate $3.80 billion. It said the transaction is expected to close in late 2024 or early 2025, subject to regulatory approvals and other closing conditions.

2. 02

   The company said Hurricane Helene in September 2024 damaged assets at its North Cove facility and disrupted operations there. It expects net sales in Q4 to be affected by about $200 million and expects to incur charges of $350 million to $400 million, which it expects to be partially offset by insurance recoveries.

3. 03

   Baxter International said net income attributable to Baxter stockholders for Q3 2024 was $140 million ($0.27 per diluted share), compared with $2.51 billion ($4.93 per share) a year earlier. It said special items reduced net income by $271 million.

4. 04

   The company said operating cash flows from continuing operations were $376 million for the 9 months ended September 30, 2024, compared with $792 million in the prior-year period. It said it made debt repayments of $827 million and dividend payments of $443 million in financing activities.

Key figures

Quarter ended September 30, 2024

Revenue

$2.7B

Operating income

$155M

Net income

$140M

EPS

$0.27

Gross profit

$1.0B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.